RAMM Pharma

RAMM Pharma Debt / Assets

The Debt-to-Assets Ratio of RAMM Pharma (RAMM.CN) as of Oct 21, 2026 is 0.20.

Debt / Assets

0.20

Last updated:

Debt-to-Assets Ratio of RAMM Pharma is 2018 0.20 . Debt-to-Assets Ratio of RAMM Pharma was 2017 - . It decreases by % lower compared to the previous year.

The RAMM Pharma Debt / Assets history

The RAMM Pharma Debt / Assets history
YEARDebt / AssetsYoY
0.20—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

RAMM Pharma Stock analysis

What does RAMM Pharma do? RAMM Pharma Corp generates revenue through cannabinoid pharmaceuticals and cannabis-based products, with brands like NettaLife, NettaPet, NettaPet Senior, NettaPet Puppies, and NettaVet targeting pet owners and veterinary markets. The company also sells cosmetics under the Cannabipiel line, including Cannabipiel Nite, Cannabipiel Body Lotion, and Cannabipiel Shampoo, catering to consumers seeking cannabinoid-infused skincare and personal care solutions. Subsidiaries such as Canapar Corp. and Medic Plast SA support production and commercialization across pharmaceutical specialties, household products, and food sectors. The firm’s product portfolio spans pharmaceuticals, pet care, cosmetics, and household items, with NettaPet and NettaVet focusing on animal health and Cannabipiel products targeting human skincare. Revenue streams include direct sales of branded items like Cannabipiel Tite and Cannabipiel Cleaning Emulsion to retail and specialty markets, while subsidiaries handle manufacturing and export operations for global distribution. Brands like Glediser SA and Yurelan SA contribute to the commercialization of diverse product categories under the company’s umbrella. RAMM Pharma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about RAMM Pharma stock

Debt-to-Assets Ratio of RAMM Pharma is 0.20 in 2018.

On Eulerpool you can find the complete historical development of Debt-to-Assets Ratio RAMM Pharma since 2006 – with annual values, charts, and detailed analysis.

The Debt-to-Assets ratio measures what percentage of a company's assets are financed through debt. Higher ratios indicate greater financial risk.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Debt-to-Assets Ratio's RAMM Pharma with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — RAMM Pharma

All Key Metrics — RAMM Pharma